In recent studies, it has been reported that the renal resistance index is effective in detecting sepsis-related acute renal failure (SA-AKI) in the early period. Similarly, urinary biomarkers \[TIMP-2\]\*\[IGFBP-7\], released in response to tubular epithelial cell stress, have been reported to indicate the presence of acute renal injury (AKI) early on, before functional loss occurs (increased creatinine). This observational study aims to evaluate the renal resistance index and urinary biomarker variation in patients diagnosed with sepsis and to investigate their usefulness in the early detection of renal dysfunction that may develop after sepsis.
Age range
18 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
Renal resistance index (RRI)
Timeframe: Immediately after sepsis diagnosis (T0, baseline, first measurement)
Renal resistance index (RRI)
Timeframe: 24 hours after sepsis diagnosis (T24, second measurement)
Renal resistance index (RRI)
Timeframe: 48 hours after sepsis diagnosis (T48, third measurement)
Urine [TIMP-2]•[IGFBP-7] biomarker
Timeframe: Immediately after diagnosis of sepsis (T0)
Urine [TIMP-2]•[IGFBP-7] biomarker
Timeframe: 24 hours after diagnosis of sepsis (T24)